The TCGA database showed that the expression of CD2, FGL2, LAT2, and SLAMF1 in tumor tissues was significantly lower than that in cancer tissues (Figures 10A–D), which was confirmed by western blotting experiments (Figure 10E). The gene discussed is FGL2; the disease is neoplasm.